indicating that QUALAS-C can differentiate between two distinct health-related quality of life (HRQOL) components. Correlations between QUALAS-C and Kidscreen-27 were also low (r≤0.44). QUALAS-C scores were significantly lower in children with SB than without (p<0.0001).
Methods:
We drafted a 27-question pilot instrument using a patient-centered comprehensive item generation/refinement process. It was administered to a sample of children 8-12 years old with Spina Bifida (SB) recruited online via social media and in person at an outpatient SB clinic (January 2013-September 2014). Healthy controls were recruited at routine pediatrician visits.
Validation and final questions were determined based on clinical relevance, high loadings on factor analysis and domain psychometrics. Children with SB also completed the validated generic Kidscreen-27 instrument.
Results: Median age of 150 participants was 9.6 years (60.7% male, 72. indicating that QUALAS-C can differentiate between two distinct health-related quality of life (HRQOL) components. Correlations between QUALAS-C and Kidscreen-27 were also low (r≤0.44). QUALAS-C scores were significantly lower in children with SB than without (p<0.0001).
Conclusions: QUALAS-C is a short, valid HRQOL tool for children with SB. It will be useful in clinical and research settings.
Introduction
Spina bifida (SB) is the most common congenital anomaly of the central nervous system, affecting 3.4 per 10,000 live births in the United States. 1 Children surviving infancy face neurological, neurosurgical, orthopedic and urological challenges. Unfortunately, studies on health-related quality of life (HRQOL) in children with SB tend to be small, single-institutional studies using limited, poorly-validated, or non-validated, instruments. [2] [3] [4] [5] [6] Others report patient satisfaction, rather than HRQOL. 7, 8 Importantly, generic HRQOL instruments developed for healthy children 9,10 may be unable to capture small, but clinically important, differences because they were not designed to measure the impact of SB on HRQOL. 11 Moreover, no validated and comprehensive SB-specific HRQOL instrument exists which incorporates bladder and bowel domains.
SB-specific HRQOL is a component of quality of life that focuses on an individual's perception of the impact of SB on their physical and psychosocial functioning. 11, 12 Assessing self-reported HRQOL is particularly important, as those with SB often report better HRQOL than perceived by their parents and caregivers. 13, 14 For this reason, instrument development requires input from individuals with SB, their parents and caregivers. 2, 11 An ideal, clinically relevant HRQOL instrument focuses on HRQOL, rather than physical function. It should also possess excellent psychometric properties and be condition-specific, yet remain short and straightforward. 2, 11 Developing such an instrument is challenging in children, since a pediatric instrument must account for children's changing cognitive capacity, reading skills and emotional development. 2 Our goal was to develop and validate a clinically useful, self-reported, diseasespecific, health-related QUAlity of Life Assessment in Spina bifida for Children (QUALAS-C).
Methods
The study protocol followed the Federal Drug Administration recommendations for patient-reported outcome instrument development 15 and was approved by the Internal Review Board (IRB 9470) and the Spina Bifida Association Professional Advisory Council.
Eligibility and exclusion criteria
Children (8 to 12 years old) with a history of myelomeniongocele or lipomeningocele requiring newborn spine surgery and living in the United States were recruited online via social media, or in person at an outpatient multidisciplinary SB clinic. While age cutoffs are somewhat arbitrary, they were necessary to generate QUALAS-C and are supported by clinical experience.
Similar ranges were successfully used for other pediatric instruments.
9,10
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The questionnaire was administered between January 2013 and September 2014. Noneligibility criteria included: diagnosis other than spina bifida (e.g. primary tethered cord, sacral agenesis), poor self-reported English proficiency ("a little bit," "some," rather than "well," "very well" on a 4-point Likert scale), developmental delay interfering with comprehension of questions, or surgery in the last month. In clinic, developmental delay was assessed by parents, health care providers and investigators, without routine psychological testing. Children participating online were assessed for significant delay by their parents. Eligible participants were excluded if they did not complete the questionnaire. Eligibility and exclusion criteria remained unchanged throughout the study. Healthy controls without SB were recruited from two local pediatric clinics during routine checkup visits.
Phase 1. Item generation
We used a patient-centered, comprehensive item generation and refinement process 
Phase 2. Development of pilot instrument
The 72 items were rated on importance by 6 children with SB and 6 parents from our SB clinic. Ratings were made on a 3-point Likert scale ("not important," "somewhat important,"
"very important"). After review by a local SB expert panel (see Acknowledgements), 27 items with the highest rankings were selected to create a more manageable and representative pilot QUALAS-C. This item reduction approach has been successfully used in the SB population. 4, 5, 16 Some items were reworded to ensure comprehension and clarity. Rewording was based on feedback from the 12 individuals rating the questions and a Health Literacy Educator (see Acknowledgments). Readability was assessed by the Flesch Kincaid Grade Level test.
17
The pilot QUALAS-C was self-administered. Questions were close-ended and numbered to avoid omission. Similar to other pediatric instruments, questions reflected the 4 weeks prior to answering the questions. 5, 10, 18 Responses used a 5-point Likert scale (never, almost never, sometimes, almost always, always), an approach successfully used in other instruments. 4, 5, 9, 10, 18 Items focusing on similar themes were grouped together to simulate the final QUALAS-C instrument.
Phase 3. Further participant recruitment
The pilot QUALAS-C and demographic questionnaire were administered anonymously to 150 children with SB and 46 controls in a cross-sectional survey (January 2013 to September 2014). Children with SB also completed the Kidscreen-27, a validated general HRQOL instrument. 9 In order to open the study to children from a variety of social and health care setting, participants were recruited through local, national and international SB organizations via social media (see Acknowledgments) and at our outpatient multidisciplinary SB clinic. Consent
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was obtained online (computer-based) or in person (clinic-based). Test-retest reliability was assessed by readministering the QUALAS-C two weeks later to participants recruited in clinic.
A $5 incentive payment was provided.
Phase 4. Refinement of instrument and factor analysis
After reviewing responses to the 27-item pilot QUALAS-C by a panel of local SB experts, one item was removed secondary to a high missing rate (>50% participants did not answer). For adequate statistical power, a factor analysis on the remaining 26 items would require at least 130 participants with SB (26x5 participants/item). 19, 20 We used factor analysis to statistically verify which of the child/parent/expert-derived items and themes work well in validated QUALAS-C domains. Briefly, extracted factors were based on 4 criteria: 21 (1) examining standard scree plots of unrotated and varimax (orthogonal) rotated factor analyses,(2) extracting factor models with different numbers of factors and rotating them using 5 additional rotations (4 orthogonal, 1 oblique) to verify factor structure stability,
ensuring extracted factors had at least 3 variables with loadings 0.4 or greater, and (4) confirming statistical properties and clinical plausibility/relevance of each resulting domain.
Based on these criteria, the final QUALAS-C instrument consisted of 2 domains with 5 items each. QUALAS-C is scored 0-100, where higher values signify higher HRQOL, and takes <5 minutes to complete.
Phase 5. Validation
We assessed several types of validity among participants with SB to determine if the 10-question QUALAS-C measures what it was intended to measure.
were established through a review by patients, families and experts. Construct validity was additionally assessed through factor analysis. For each domain score, we calculated the mean, standard deviation (SD), median, range and the percentage of subjects scoring the minimum (floor) and maximum (ceiling). Reliability, or reproducibility, was assessed by measuring internal consistency and test-retest reliability. 22 Internal consistency refers to the degree of correlation between items in the instrument. It was measured by Cronbach's alpha (0.7-0.9 signifying robust consistency without redundancy). 22 Two-week test-retest reliability was assessed by Intraclass Correlation Coefficient (ICC), which accounts for the direction of change (≥0.7 indicating good reliability), using a SAS macro written by Lu and Shara. 23 Convergent and divergent validity evaluates conceptual independence or redundancy.
Convergent validity evaluates the degree to which QUALAS-C scores converge with other instruments measuring similar outcomes. On the other hand, divergent validity evaluates the degree to which QUALAS-C scores diverge from those measured by dissimilar instruments. To assess this, we calculated Pearson correlation coefficients (r) among QUALAS-C domains and with Kidscreen-27 domains. To quantify effect size, we used a previously established method of dividing the mean difference between children with SB and controls by the SD of the control population. 24, 25 Several distribution-based approaches were used to determine the minimal clinically important difference that could be detected. Estimated point differences were determined using (1) 0.5 SD, 26 or (2) internal consistency or (3) test-retest reliability in the formula
SD´(1-reliability)
. 27 We selected the most conservative, largest point difference calculated
by the three methods as the minimally important score difference for each domain.
To further evaluate construct validity, domain scores between children with SB and controls were compared using a t-test. A critical p=0.05 was used. All statistical analyses were performed using SAS software (v9.4, SAS Institute, Cary, NC).
Results

Phases 1 and 2. Item generation and Development of pilot instrument
The 27-item pilot instrument was developed in a multifaceted, patient-centered fashion (Figure 1 ). Ten semi-structured interviews lasted a mean of 20 minutes.
Phase 3. Further participant recruitment (Demographics)
Of 104 clinic patients screened, 63 (60.6%) met eligibility criteria, and 53 (84.1%) were ultimately enrolled (Figure 2 ). Of 110 online participants, 109 (99.1%) met eligibility criteria, and 97 (89.0%) were enrolled. We observed no significant differences in gender and age between eligible children who were and were not enrolled. Forty-six controls without SB were enrolled.
Median age of 150 participants was 9.6 years (60.7% male, 72.7% Caucasian), similar to controls (p≥0.10) ( Table 1) . Half (57.3%) were community ambulators (walked with/without aids, using wheelchair for only long trips) 28 Correlations between QUALAS-C domains were low (r=0.51), indicating that QUALAS-C can differentiate between two distinct HRQOL components (eTable 3). Correlations between QUALAS-C and Kidscreen-27 domains were also low (r≤0.44), indicating that these instruments assess different aspects of HRQOL. Domain characteristics were similar for participants recruited online and in clinic.
The minimally important difference was ≥10 for either domain (range of values: 9.7-10.7).
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QUALAS-C scores for controls were significantly higher than children with SB for both domains (p<0.0001), each with a large effect size (≥1.1) (eTable 4). Similar to children with SB, missing data was low for each domain (Esteem and Independence: 0.0%, Bladder and Bowel: 0.0%).
Comment
We present a short, novel, validated HRQOL instrument developed specifically for children with SB. QUALAS-C is composed of items relevant to children with SB, their families and clinicians, including a comprehensive domain focusing on bladder and bowel dysfunction.
We also report minimally important differences in HRQOL scores, which may help patients, clinicians and researchers to focus on differences that are statistically and clinically significant.
Three previously published SB-specific HRQOL instruments in children have serious limitations. Importantly, none have a patient-reported version for children younger than 13 years old. [4] [5] [6] Furthermore, each instrument has 44 to 51 items, making them cumbersome and timeconsuming. Since none of these instruments was designed using factor analysis, all remain suspect for item redundancy and appropriate domain groupings. In addition, the Hydrocephalus Outcome Questionnaire was developed without input from individuals with SB. 5 While children, families and SB experts overwhelmingly endorsed bladder/bowel care and incontinence as important aspects of HRQOL, only the Fecal Incontinence and Constipation QOL instrument contains items addressing bowel issues. 6 Finally, it remains unclear what score difference, or change, may be clinically relevant when using existing instruments.
Our primary goal was to create a clinically meaningful and useful instrument, rather than a research tool. The low rate of missing data suggests that QUALAS-C is not difficult to complete. If only 4 of 5 responses are provided for a domain, we suggest using the mean of these items for a domain score. 29 QUALAS-C domains can be used together or on their own.
QUALAS-C was developed because current generic HRQOL instruments are insufficient for children with SB. This is largely due to the fact that instruments developed for healthy children fail to capture aspects of HRQOL important to people living with SB. As the fundamental concept of HRQOL may be different between individuals with and without SB, QUALAS-C scores of healthy controls likely hold no clinical relevance and were used only to calculate validation statistics. QUALAS-C scores may be best compared longitudinally to the same person over time, or between children with SB. Finally, QUALAS-C evaluates the specific impact of SB on HRQOL, rather than generic HRQOL or global quality of life.
Our study has several limitations. While we cannot verify how much assistance online participants received from their parents. It should be noted that while QUALAS-C was often filled out with some parental help in clinic (i.e. reading questions), all questions were assessed from the child's perspective. It is unrealistic to insist that children with SB fill out a HRQOL instrument completely on their own, as few would be able to do so.
Although we did not detect evidence of significant selection bias, as eligible participants who were and were not enrolled had similar demographics, study participants may have fewer developmental and functional limitations than the general SB population and non-participants.
An external validation is needed.
While we did not use anchor-based methods to calculate minimally important differences, distribution-and anchor-based methods have been shown to give comparable results.
30
QUALAS-C was validated only for children with SB. Whether it can be used in other 
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The goal of caring for a child with spina bifida should be to help them live as normal a life as possible. In order to achieve this goal, we as providers may perform procedures that are medically necessary as well as those that help them to become more independent and "fit" better into everyday life. Who decides what is "normal"? The challenge of managing patients with a birth defect that results in varying degrees of physical limitations, bowel and bladder dysfunction, and neurologic issues becomes even more difficult as the child ages. Along with the potential need of undergoing multiple surgeries, these individuals must work toward independence in the face of aging parents or caregivers, integrate themselves into school and work, strive for a sense of belonging into a society filled with discrimination and prejudice, and ultimately be provided adequate access to medical care as they transition into adulthood. Despite advances in medical care, it is still quite difficult to compare outcomes across institutions as we have yet to standardize our approach to patients with spina bifida. The current paper highlights the importance of having a tool to truly measure health related quality of life in this patient population. As stated, quality of life can be perceived very differently between guardian and patient yet, both reported outcomes are extremely important to us as caretakers to ensure that we are on the right path to counsel and prepare both guardian and child for their journey ahead.
Despite the mentioned limitations and need for external validation, this construction of a selfreported health related quality of life assessment tool is one more step to helping these children communicate how their lives are affected by spina bifida. In return, we can use this information to help personalize our approach to each individual patient to help them achieve the best possible outcomes.
